This is a working overview of pentadecapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-07-08 and is reviewed periodically as new material appears.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection of dry material |
| Solubility | Soluble in water | Polar aqueous solvent class |
| Typical storage | Minus 20 degrees Celsius, desiccated, dark | Applies to the lyophilized form |
| Purity assessment | Reversed-phase HPLC | Ultraviolet detection, area percent |
| Identity confirmation | Mass spectrometry | Measured mass compared with theoretical value |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
The Welsh Conservatives are absent from a Senedd debate concerning their former leader, Andrew RT Davies, but reject allegations they are boycotting the chamber's disciplinary process. 6 February – Chris McEleny is suspended as general secretary of the Alba Party following allegations of gross misconduct. 7 February – Reform UK chairman Zia Yusuf tells the BBC's Political Thinking podcast that history will judge Boris Johnson as one of the most damaging prime ministers in British history. 8 February – Health Minister Andrew Gwynne is sacked by the prime minister after the Mail on Sunday reported he sent a string of abusive and insulting WhatsApp about constituents and colleagues. Gwynne apologises for what he describes as the "badly misjudged" messages. 9 February – Conservative shadow minister Alex Burghart tells the BBC's Sunday with Laura Kuenssberg there is "not a conversation to be had" about suggestions of an electoral pact with Reform UK. Oliver Ryan, MP for Burnley, becomes the second MP to apologise for inappropriate comments made in a WhatsApp chat. 10 February – Peter Mandelson begins his tenure as United Kingdom ambassador to the United States, and tells the BBC the UK must respect President Donald Trump's "strong and clear mandate for change". Oliver Ryan is suspended from the Parliamentary Labour Party over his membership of a WhatsApp group in which offensive messages were exchanged. King Charles III gives the prime minister and deputy prime minister a tour of his environmentally friendly, sustainable housing project at Nansledan in Cornwall.
The name Singapura supplanted Temasek sometime before the 15th century, after the establishment of the Kingdom of Singapura on the island by a fleeing Sumatran Raja (prince) from Palembang. However, the precise time and reason for the name change is unknown. The semi-historical Malay Annals state that Temasek was christened Singapura by Sang Nila Utama, a 13th-century Sumatran Raja from Palembang. The Annals state that Sang Nila Utama encountered a strange beast on the island that he took to be a lion. Seeing this as an omen, he established the town of Singapura where he encountered the beast. The second hypothesis, drawn from Portuguese sources, postulates that this mythical story is based on the real life Parameswara of Palembang. Parameswara declared independence from Majapahit and mounted a Lion Throne. After then being driven into exile by the Javanese, he usurped control over Temasek. He may have rechristened the area as Singapura, recalling the throne he had been driven from. Under Japanese occupation, Singapore was renamed Syonan-to (Japanese: 昭 南, Hepburn: Shōnan), meaning 'light of the south'. Singapore is sometimes referred to by the nickname the "Garden City", in reference to its parks and tree-lined streets. Another informal name, the "Little Red Dot", was adopted after an article in the Asian Wall Street Journal of 4 August 1998 said that Indonesian President B. J. Habibie referred to Singapore as a red dot on a map.
== Brand names == Felviten Halpen Hepasulfol - Franco-Indian Pharmaceuticals Heporal Mucinol - Sanofi-Aventis Sialor - Paladin Laboratories; Pharmascience; Solvay; Zuoz Pharma Sonicur - Solvay Sulfarlem - Solvay; Aguettant; Edward Keller; Sanofi-Aventis Sulfarlem S - EG Labo Tiopropen Tiotrifar
==== All Day I Dream About Sport ==== A short film titled All Day I Dream About Sport, co-created by Williams and Gabriel Moses, was premiered at the High Museum of Art on February 15, 2025, in an event hosted by German sportswear brand Adidas. Although not explicitly tied to Clipse, the film's soundtrack included a preview of an original Pusha T song produced by Williams titled "Mike Tyson Blow to the Face". The song was later confirmed for Let God Sort Em Out, being referred to under the shortened name "Mike Tyson".
Sources: en.wikipedia.org
=== Metabolic niche partitioning === In 2010, exometabolomics analysis of the cyanobacterium, Synechococcus sp. PCC 7002 by Baran, et al. revealed that this photoautotroph could deplete a diverse pool of exogenous metabolites. A follow-up exometabolomics study on sympatric microbial isolates from biological soil crust, which exist in communities with cyanobacteria in the desert soils of the Colorado Plateau, suggested that metabolite niche partitioning exists in these communities, where each isolate only utilizes 13-26% of metabolites from the soil
Orlando Figes (born 1959) historian, author, known for works on Russian history; has also contributed on European history with his book The Europeans (2019); has served on editorial board of journal Russian History; writes for international press, broadcasts on television and radio, reviews for The New York Review of Books, and is fellow of Royal Society of Literature; was historical consultant on film Anna Karenina starring Keira Knightley and Jude Law with screenplay by Tom Stoppard; historical consultant on BBC War & Peace television series. Antonia Forest (26 May 1915 – 28 November 2003) was the pseudonym of Patricia Giulia Caulfield Kate Rubinstein, an English writer. She wrote 13 books for children, published between 1948 and 1982. Her 10 best-known works concern the doings of the fictional Marlow family. Forest also wrote two historical novels about the Marlows' Elizabethan ancestors. Dov Forman (b. 2003); author and social media creator; uses social media to educate people about the Holocaust and Judaism, and to advocate against antisemitism; co-authored Lily's Promise, a book documenting the Holocaust; received the 'Points of Light' award for services to Holocaust education; included in the inaugural TIME100 Creators list; was selected for the inaugural Masa Changemakers List, honouring 18 global leaders from Masa's 200,000+ alumni. Forman was a Masa participant during his time in Israel as a Nitzavim Fellow, studying at the Hebrew University of Jerusalem and a Talmudic college in Jerusalem.
== Early life == Markin was born and raised in Lincoln, Nebraska. He received a Bachelor of Science degree in 1977 from Nebraska Wesleyan University, where he majored in chemistry with minors in mathematics and physics. He received a Ph.D. in chemistry from the University of Nebraska–Lincoln in 1980; he earned his medical degree from the University of Nebraska Medical Center (UNMC) in 1983; he completed his residency in pathology and laboratory medicine at UNMC in 1986. He has been on the UNMC faculty since 1986. His professional and academic research interests have focused on clinical laboratory automation including robotics, information systems, medical utilization management, business efficiency modeling, adult and pediatric pathology, liver/gastrointestinal pathology, telehealth, telemedicine, technology development and mobile health.
== Metabolic fate after dietary intake == Naringenin can be produced from dietary naringin by the hydrolytic action of the liver enzyme naringinase. The fate and biological roles of naringenin are difficult to study because naringenin is rapidly metabolized in the intestine and liver, and its metabolites are destined for excretion. The biological activities of naringenin metabolites are unknown, and likely to be different in structure and function from those of the parent compound.
== History == Mobile refrigeration with ice from the ice trade began with reefer ships and refrigerator cars (iceboxes on wheels) in the mid-19th century. The term cold chain was first used in 1908. The first effective cold store in the UK opened in 1882 at St Katharine Docks. It could hold 59,000 carcasses, and by 1911 cold storage capacity in London had reached 2.84 million carcasses. By 1930 about a thousand refrigerated meat containers were in use which could be switched from road to railway. Mobile mechanical refrigeration was invented by Frederick McKinley Jones, who co-founded Thermo King with entrepreneur Joseph A. "Joe" Numero. In 1938 Numero sold his Cinema Supplies Inc. movie sound equipment business to RCA to form the new entity, U.S. Thermo Control Company (later the Thermo King Corporation), in partnership with Jones, his engineer. Jones designed a portable air-cooling unit for trucks carrying perishable food, for which they obtained a patent on 12 July 1940, subsequent to a challenge to invent a refrigerated truck over a 1937 golf game by associates of Numero's, Werner Transportation Co. president Harry Werner, and United States Air Conditioning Co. president Al Fineberg, This technology has been frequently in use since the 1950s, when it was most often used for preserving animal-based cells or tissue. As medical breakthroughs, such as in cancer treatment, have taken place, the demand for cold chain systems has grown. The COVID-19 pandemic and its associated vaccinations, have caused vastly increased need.
Sources: en.wikipedia.org
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.
Mass spectrometry establishes the molecular mass, and reversed-phase chromatography reports purity. A certificate of analysis typically combines both results.
Solutions degrade faster than the dry powder, particularly at room temperature. Portioning into single-use aliquots and freezing reduces losses from repeated thawing.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.